Nanayakkara, S.
423  Ergebnisse:
?
 
?
3

Prevalence and Outcomes of Acute Coronary Syndrome Patients..:

Ball, J. ; Dinh, D. ; Brennan, A....
Heart, Lung and Circulation.  32 (2023)  - p. S364 , 2023
 
?
4

Identifying Patients at High Risk of Left Atrial Appendage ..:

Segan, L. ; Nanayakkara, S. ; Spear, E....
Heart, Lung and Circulation.  32 (2023)  - p. S197-S198 , 2023
 
?
 
?
 
?
7

Sex-Specific Differences in Modifiable AF Risk Factors:

Segan, L. ; Canovas, R. ; Nanayakkara, S....
Heart, Lung and Circulation.  32 (2023)  - p. S215-S216 , 2023
 
?
8

Long-Term Transcatheter Aortic Valve Implant Outcomes Accor..:

Quine, E. ; Dagan, M. ; William, J....
Heart, Lung and Circulation.  32 (2023)  - p. S441 , 2023
 
?
9

Haemodynamic and Metabolomic Effects of Dapagliflozin in He..:

Dagan, M. ; Bloom, J. ; Vizi, D....
Heart, Lung and Circulation.  32 (2023)  - p. S405 , 2023
 
?
10

Evaluating PCSK9 Inhibitor Eligibility and Use in the Secon..:

He, W. ; Jape, D. ; Nanayakkara, S..
Heart, Lung and Circulation.  32 (2023)  - p. S387-S388 , 2023
 
?
 
?
 
?
13

Influence of Impaired Conduction on Exercise Haemodynamics ..:

Hogarty, J. ; Comella, A. ; Nanayakkara, S....
Heart, Lung and Circulation.  32 (2023)  - p. S163-S164 , 2023
 
?
 
?
15

Prevalence and outcomes of acute coronary syndrome patients..:

Ball, J ; Dinh, D ; Brennan, A...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
 
1-15